Latest in News & Research
Patients With Psoriasis Have Elevated Risk for Complications After Total Hip Arthroplasty
Higher superficial SSI, deep SSI, wound complications, sepsis, aseptic revision reported for those with cutaneous psoriasis
AAD: Significant Benefits Seen for Brepocitinib 30 mg in Dermatomyositis
Mean Total Improvement Score significantly improved at week 52; brepocitinib was superior for all nine secondary outcomes
AAD: Timolol Maleate Gel Effective for Superficial Infantile Hemangioma
Topical timolol maleate 0.5 percent gel applied three times daily for 24 weeks is effective and safe
Risk for Skin Cancer Elevated for Patients With Chronic Lymphocytic Leukemia
Patients with CLL have increased risk for most skin cancer subtypes and higher risk for skin cancer-specific metastasis and death
FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
Experts warn tanning beds raise skin cancer risk
FDA Approves Icotyde for Moderate-to-Severe Plaque Psoriasis
Icotyde is the first and only targeted oral peptide that blocks the IL-23 receptor
Punch Excision Plus Radiotherapy Effective for Trunk Keloids
Perioperative and postoperative RT yield equivalent cosmetic outcomes at 18 months postoperatively
AI Achieves Comparable Melanoma Diagnostics to Dermatologists
Higher sensitivity and specificity seen in single study reporting on AI-assisted dermatologists
Risk for Death Reduced With Sentinel Node Biopsy in Melanoma
Significantly reduced risk for death from melanoma and reduced risk for recurrence reported for those undergoing SNB
Early-Onset Androgenetic Alopecia Linked to Diabetes Mellitus Risk
Androgenetic alopecia linked to DM, impaired fasting glucose in adults younger 45 years but not those older than 45 years
Dupilumab Restores Skin Barrier Function in Pediatric Atopic Dermatitis
No significant differences seen in transepidermal water loss, epidermal thickness for AD versus healthy skin at weeks 16 and 28
Roflumilast Cream Has Long-Term Safety, Efficacy in Young Children
Atopic dermatitis signs/symptoms continued to improve at treatment week 56 among children aged 2 to 5 years
AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma
Patients receiving pembrolizumab or nivolumab exhibited modest reduction in exacerbation rates at 24 months
Annual Sunscreen Protection Can Cost as Little as $40 per Year
Findings depend on how expensive a sunscreen people buy and how much of their skin they protect with hats and clothing
FDA Approves Sotyktu for Adults With Active Psoriatic Arthritis
Compared with placebo, Sotyktu significantly improves disease activity and quality of life
Patients With Hidradenitis Suppurativa Have Increased Risk for Self-Harm
Patients with HS have a higher hazard of suicide; those who die by suicide more often have prior self-harm episodes
Dermoscopic Patterns Identified for Acral Lentiginous Melanoma
Parallel ridge pattern was the most sensitive and specific feature for ALM versus benign acral nevi
Collagen Supplements Beneficial for Dermal, Bone, Musculoskeletal Health
Collagen supplementation consistently associated with favorable outcomes for skin, musculoskeletal health, osteoarthritis conditions
JAK Inhibitor + 308-nm Excimer Laser Treatment Promising for Pediatric Vitiligo
Significantly higher repigmentation rates seen for pediatric patients receiving JAK inhibitor versus topical tacrolimus therapy combined with 308-nm excimer laser
Variables Identified for Time to Recurrence in Melanoma
Variables include thickness, ulceration, tumor site, neurotropism, lymphovascular invasion, mitoses
Plant-Based Diets May Aid Symptoms of Psoriasis
Higher meat consumption tied to higher psoriasis severity, while higher plant-based consumption tied to lower severity
Ultraviolet-Induced Fluorescent Dermoscopy Beneficial for Assessing Cutaneous Tumors
Keratin, comedo-like openings, and fissures and ridges better seen under UV-FD, as was border definition of lesions
Biologics, Phototherapy Compared in Plaque Psoriasis Treatment
Biologics provide largest quality-of-life gain; for patients, mean willingness to pay was highest for biologics
24 of 1289